BridgeBio Oncology Therapeutics Inc (BBOT) Stock Price, Quote, News & History

BBOTNASDAQ
$4.95
-0.57-10.33%
At close: Sep 11, 5:00 PM EST
$4.94
-0.01-0.2%
After Hours: 5:13 PM EST

BridgeBio Oncology (BBOT) Stock Price, Quote, News & History | Benzinga

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Cash Flows

Operating Cash Flow (TTM)
-151.28M
Investing Cash Flow (TTM)
-191.36M
Financing Cash Flow (TTM)
365.18M
Free Cash Flow (TTM)
-151.56M
Capital Expenditure (TTM)
-284.00K
Net Change in Cash (TTM)
22.55M

Analyst Trends and Forecast

1
May
1
Jun
1
Jul
1
Aug
6
Sep
Buy
Hold
Sell
Strong Sell

Analyst Rating and Forecast

12345
4.5
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Valuation Metrics

Enterprise Value
$218.56M
PE Ratio (TTM)
-
PE Ratio (FWD)
-
PEG Ratio (TTM)
-
PS Ratio (TTM)
-
PB Ratio (TTM)
1.37
Earnings Yield % (TTM)
-41.26%
Earnings Yield % (FWD)
-49.36%
EV / EBITDA (TTM)
-
Price / EBITDA (TTM)
-
Price / Free Cash Flow (TTM)
-
Book Value / Share
$4.03

Company Debt

Total Debt
-
LT Debt
-
LT Debt Issuance (TTM)
-
LT Debt Repayment (TTM)
-
Total Cash
$54.06M
Debt to Equity
0.01
Issuance of Debt (TTM)
-
Repayment of Debt (TTM)
-

Key Statistics

Open
$5.53
Close
$4.95
Volume / Avg.
1.63M / 426.03K
Day Range
$4.90 - $5.62
52 Wk Range
5.48 - 14.87
Market Cap
$396.06M
P/E Ratio
-
Dividend Yield
-
Exchange
NASDAQ
RSI
17
Short Interest
21.69%
Days to Cover
20.77

About

Sector
Health Care
Industry
Biotechnology
BridgeBio Oncology Therapeutics Inc, is a clinical-stage biotechnology company that aims to transform the lives of patients with cancers driven by RAS and PI3Ka, the two frequently mutated oncogenes. The Company operates in one operating and reportab...
Show More
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

FAQ

Q

How do I buy BridgeBio Oncology (BBOT) stock?

A

You can purchase shares of BridgeBio Oncology (NASDAQ:BBOT) through any online brokerage.

View our list of the best stock brokerages

Q

Who are BridgeBio Oncology (BBOT) competitors?

Q

What is the forecast, or price target, for BridgeBio Oncology (BBOT) stock?

A

BridgeBio Oncology has a consensus price target of $22.50.

Q

What is the current price for BridgeBio Oncology (BBOT)?

A

The stock price for BridgeBio Oncology (NASDAQ: BBOT) is $4.94 last updated September 11, 2026 at 5:13 PM EDT.

Q

Does BridgeBio Oncology (BBOT) pay a dividend?

A

There are no upcoming dividends for BridgeBio Oncology.

Q

When is BridgeBio Oncology (NASDAQ:BBOT) reporting earnings?

A

BridgeBio Oncology does not have any upcoming earnings scheduled.

Q

Is BridgeBio Oncology (BBOT) going to split?

A

There is no upcoming split for BridgeBio Oncology.

Q

What sector and industry does BridgeBio Oncology (BBOT) operate in?

A

BridgeBio Oncology is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.